A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Clinical trial NCT05785819 · TERMINATED

Trial details

NCT number: NCT05785819
Sponsor: Veralox Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytopenia, Immune Heparin Induced Thrombocytopenia

Start date: 2023-09-26
Primary completion: 2025-11-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.